Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Zenagamtide

A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overwe

Novo Nordisk · Phase 1 · Recruiting · Enrollment 320

NCT07815067

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Zenagamtide subcutaneous (s.c.)n/rn/rn/rn/r
Zenagamtide oraln/rn/rn/rn/r

Not shown

  • Zenagamtide subcutaneous (s.c.): endpoint not reported
  • Zenagamtide oral: endpoint not reported